Physiopedia’s Post

The recording of our webinar titeld "How can digital pathways streamline the workflow in Rheumatology" is now available. If you missed it, please watch it here: https://lnkd.in/e-JaHe7j

🚨NEW CLINICAL TRIAL FOR BACK PAIN NOW ENROLLING🚨 Join me for the Regenexx Degenerative Disc Disease Clinical Trial Webinar 📆 When: Saturday, Nov 18, 2023, @ 1:00 PM (MST) 📍 Where: Online - Follow Eventbrite link below Webinar Highlights: 1. Overview of the Lumbar DDD Clinical Trial. 2. Understanding the inclusion and exclusion criteria for patient enrollment. 3. Insights into the injection protocol and the treatment being investigated. 4. The significance of this study in the current treatment landscape. 5. Q&A session. https://lnkd.in/d72tkHYt

Getting ready for American College of Rheumatology with the best team in the business. Such a great opportunity to help educate on the systemic impact of uncontrolled gout and share the latest data on trends, outcomes and disease insights. Together we're helping change how gout is understood and improving care for patients #acr23

Really useful tool for clinicians #asthmadiagnosis #gettingitright #improvedpatientoutcomes

🔥Do you know when to switch to 2nd line treatment with advanced #HCC patients? Check out our first interactive patient case video from Dr Timon Vandamme and follow a patient's journey through HCC and make treatment selection and sequencing decisions Interact and engage with valuable information, challenging information, and clickable resources, you'll choose your preferred 1st line treatment option for this patient, when to switch to 2nd line treatment, and which 2nd line option to recommend. Clinical Takeaways ✅#IO based treatments are the first choice for patients with advanced HCC without active auto-immune disease and without #liver transplant https://ow.ly/TxJZ50QlkX8 #MedEd

3 weeks to go until our next webinar - there is still time to register for your free place 🔔 Join our expert panel as they look at the value of Delphi panels in accelerating patient access to innovative treatments. This webinar aims to provide a comprehensive overview of the Delphi panel methodology, its application in supporting reimbursement decisions and practical considerations for effectively implementing this approach as part of your evidence generation strategy. By attending this webinar, you will: - understand the Delphi panel methodology, including its origins and structured approach for generating expert consensus - discover the value of Delphi Panels in supporting reimbursement decisions - explore practical considerations for implementation in your evidence generation strategy This session is particularly relevant for Market Access teams looking to leverage robust expert opinion and consensus to strengthen their evidence packages and value propositions for reimbursement submissions, particularly for rare disease submissions where clinical data may be limited and expert perspectives are crucial to contextualise evidence for local settings. Click the link to register for your free place now: https://lnkd.in/eN9Fmrpf #webinar #delphipanels #marketaccess #reimbursement

FREE WEBINAR: Pituitary disease isn’t something we see every day in clinical practice, but with signs and symptoms that are often insidious, vague and, of course, vary depending on which area of the gland is affected, it can be a real challenge to pick up. Patients frequently face long delays in diagnosis, with a significant impact on their life expectancy and quality of life. This webinar will equip you with the knowledge and skills to make a real difference to your patients with pituitary disease, as well as knowing when to suspect the diagnosis and what to do when you do! #PituitaryDisease #HotTopics #FreeCPD

Our expert panel discusses how to best incorporate the patient perspective into the design and execution of #NASH, increasingly known as #MASH (metabolic-associated steatohepatitis) #clinicaltrials, an area of vast industry interest as global rates of disease rise. Access this on-demand webinar ➠ https://bit.ly/3Nnpdmo

We recently brought together an expert panel to discuss how to best incorporate the patient perspective into the design and execution of #NASH, increasingly known as #MASH (Metabolic-associated Steatohepatitis) #clinicaltrials, an area of vast industry interest, as global rates of disease rise. Gain insights on demand ➠ https://bit.ly/3Nnpdmo

Build your knowledge in the care of people with #rheum disease with the Advanced Rheumatology Course (ARC). Available in 19 individual activities or as a comprehensive course—perfect for NPs, PAs, & PCPs. Purchase the entire set for $2,399 or individual modules for $180 each. ACR/ARP members receive a discount on ARC—$1,999 for the entire set and $150 per module, making membership a significant value. Explore ARC → https://acr.tw/3Q1otW2